New vaginal ring could make preterm birth prevention easier
NCT ID NCT06668896
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study tests a new progesterone vaginal ring (8mg or 12mg daily) against a standard progesterone insert (100mg) in 60 healthy postmenopausal women. Researchers will measure how much progesterone gets into the blood over 14 days. The goal is to see if the ring delivers the hormone effectively, which could later be tested to prevent preterm birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
progesterone
What this could lead to
If successful, this could lead to a more convenient progesterone delivery method to help prevent preterm birth.
What could go wrong
This is a very early Phase 1 study in healthy volunteers, not pregnant women. It only measures drug levels, not whether the ring prevents preterm birth. Many early-stage trials do not lead to approved treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-TERM BIRTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••